Fig. 8: Graphical summary of the antimetastatic effect of s-mRNA.
From: Synthetic short mRNA prevents metastasis via innate-adaptive immunity

Since the chemically synthesized short mRNA (IL1β-mRNA_OMe_AE) is RNase resistant, it can be used to stimulate NK and CTL via the ZC3H12D receptor in vivo. These immune cells enhance its Granzyme B-dependent tumoricidal activity without inducing inflammatory responses that cause severe side effects.